REPROCELL and Gameto Collaborate to Enhance Assisted Fertility Using iPSCs
REPROCELL Inc. has recently announced a licensing agreement with Gameto Inc., a female-led biotech firm dedicated to transforming women’s healthcare. This agreement grants Gameto a non-exclusive right to utilize REPROCELL’s StemRNA™ Clinical Seed iPSCs. Gameto intends to leverage this clinical-grade iPSC line for the development and commercialization of its innovative program, Fertilo, which aims to […]
Stem Cells: Revolutionizing Autoimmune Treatment with Kyverna & ElevateBio
Kyverna Therapeutics, a clinical-stage cell therapy company, and ElevateBio, a technology-driven company specializing in cell and gene therapies, have announced a partnership aimed at advancing the development and manufacturing processes for Kyverna’s Ingenui-T-derived chimeric antigen receptor (CAR) T-cell therapies. The Ingenui-T platform, developed by Kyverna, is optimized for autologous CAR-T cell manufacturing for autoimmune diseases, […]
Study Published in Nature Reveals Discovery of Unique Vertebral Stem Cells with Potential to Revolutionize Patient Care
A groundbreaking study, conducted by a collaborative team from the Hospital for Special Surgery (HSS) and Weill Cornell Medicine and published in Nature, has unveiled the existence of unique vertebral stem cells in the spine. This discovery is pivotal, as it contradicts the long-held belief that all bones form through a universal ossification process. The […]
New cell therapy facility enters fight against chronic diseases
The Novo Nordisk Foundation has committed DKK 950 million (EUR 127 million) to establish the Novo Nordisk Foundation Cellerator, a world-class facility aimed at advancing cell therapies for chronic diseases like heart failure, Parkinson’s, kidney disease, type 1 diabetes, and several forms of cancer. This facility will be located at the Technical University of Denmark […]
Akari Therapeutics to Host Webinar on HSCT-TMA and the Potential of Nomacopan
Akari Therapeutics, Plc, a leading biotechnology company specializing in advanced therapies for autoimmune and inflammatory diseases, has announced its plans to host a virtual key opinion leader event on October 19, 2023, at 11:30 am ET. The primary focus of this event will be to discuss the patient care landscape for hematopoietic stem cell transplant-related […]
BD² Announces $18 Million in Grants to Understand Biology of Bipolar Disorder
BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder has recently declared its inaugural round of Discovery Research grants, amassing a total of $18 million. This significant financial commitment is aimed at fostering collaboration and directing concentrated funding towards understanding the biology of bipolar disorder. Key Highlights: Conclusion: BD²’s commitment to understanding bipolar disorder, especially through […]
Orchard Therapeutics Moves Closer to a Breakthrough Treatment for MLD
Orchard Therapeutics, a global leader in gene therapy, has recently made significant strides in the development of a treatment for metachromatic leukodystrophy (MLD). Here’s a detailed summary of the press release: Key Developments: Insights from Orchard Therapeutics: Bobby Gaspar, M.D., Ph.D., co-founder and CEO of Orchard Therapeutics, expressed the company’s commitment to addressing the urgent […]
BioRestorative Therapies Activates Northwell Health for Phase 2 Clinical Trial on Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc., a clinical-stage company specializing in stem cell-based therapies, has announced the activation of Northwell Health, the largest healthcare provider in New York State, for its ongoing Phase 2 clinical trial targeting chronic lumbar disc disease (cLDD). This activation permits patients in New York to participate in the BRTX-100 trial. The collaboration between […]
Neuroplast Completes Phase II Clinical Trial Inclusion for Traumatic Spinal Cord Injury
Neuroplast, a Dutch clinical-stage biotech company, has successfully concluded the patient inclusion for its Phase II clinical trial, focusing on Traumatic Spinal Cord Injury (TSCI). Here are the key details: Thought-Provoking Questions/Insights: Original Press Release
Excision BioTherapeutics’ Groundbreaking Gene Therapy for HIV: A Closer Look
Excision BioTherapeutics, a clinical-stage biotechnology company, has recently made headlines with its announcement regarding the publication of pre-clinical data supporting its innovative CRISPR-based gene therapy candidate, EBT-101. This therapy is designed to functionally cure HIV-1. Here’s a detailed summary of the press release: Key Findings: CEO’s Statement: Daniel Dornbusch, the Chief Executive Officer of Excision, […]